Adolor 8-K 2008
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) September 3, 2008
(Exact Name of Registrant as Specified in Charter)
Registrants telephone number, including area code: (484) 595-1500
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 8.01 Other Events.
On September 3, 2008, in connection with its application for extension of confidential treatment, Adolor Corporation (the Company) re-filed that certain Option and License Agreement effective June 10, 1998 by and between the Company and Roberts Laboratories Inc. (the Roberts Agreement) in order to include in the Companys publicly filed materials certain portions of the Roberts Agreement for which confidential treatment was previously granted but for which such treatment is no longer necessary. The Roberts Agreement was originally filed as Exhibit 10.2 to the Companys Registration Statement on Form S-1 (Registration No. 333-96333) filed on February 8, 2000. A copy of the Roberts Agreement is attached hereto as Exhibit 10.1.
Item 9.01. Financial Statements and Exhibits.
10.1 Option and License Agreement effective June 10, 1998 by and between Adolor Corporation and Roberts Laboratories Inc.1
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 3, 2008